ESTIMATION OF THE ANXIOLYTIC-LIKE EFFECT OF THE Î²-CARBOLINE ALKALOID HARMINE ON STRESSED PREGNANT RATS
Objective: During the last decade, the role of the Î²-carboline alkaloid harmine has essentially been studied with regard to its anxiolytic effect, as it was done in our laboratory; therefore, this study has been progressed to cover the effect of this alkaloid on pregnant wistar rats.
Methods: The molecule was used at doses of 10 mg/kg, 15 mg/kg, pregnant female rats were divided into three groups according to the stage of pregnancy: first, second, and the third week of pregnancy. Each group has been subdivided into seven subgroups: control group, two treated groups with harmine, acute footshock stress at 1,2mA, sub-acute footshock stress at 0,4mA, psychological stress, and the treated group that footshocked after with 1,2mA, all groups were carried out open field test, plus maze test and light/dark box test.
Results: Thigmotaxis is reflected by the significant increase in the traveled distance in peripheral area in the open field of the three groups â€˜weeksâ€™ at dose of 10 mg/kg, the enhancement in the number and time of rearing, at both doses, during the second and the last week, the significant increase in the number of entries â€˜in open armsâ€™ in plus-maze during the first and third weeks at 15 mg/kg, and the significant decreased in time spent in the light compartment of the light/dark box at the same dose of all groups â€˜weeksâ€™ were noticed, which confirm the anxiolytic effect of the alkaloid, even in the case of the footschock stressed pregnant rats of all groups â€˜weeksâ€™ that enhancement of number of enties into open arms during the plus maze test.
Conclusion: So we can conclude that the anxiolytic effect of harmine not shortening to male rats, but expands to female pregnant wistar rats, and establishes its effect by diminishing time in light compartment of light/dark box and number of entries in open arms of plus maze, in other hand, the increase in the number and the time of rearing reflects the enhancement of exploratory behavior.
2. Callaway JC, McKenna DJ, Grob CS, Brito GS, Raymon LP, Poland RE, et al. Pharmacokinetics of hoasca alkaloids in healthy humans. J Ethnopharmacol 1999;65:243-56.
3. Yritia M, Riba J, OrtunÃµ J, Ramirez A, Castillo A, Alfaro Y, et al. Determination of N, N-dimethyltryptamine and Î²-carboline alkaloids in human plasma following oral administration of Ayahuasca. J Chromatogr 2002;779:271-81.
4. Glennon RA. Serotonin receptor interactions of harmaline and several related Î²-carbolines. Life Sci 1981;29:861-5.
5. Shih JC, Thompson RF. Monoamine oxidase in neuropsychiatry and behaviour. Am J Hum Genet 1999;65:593-8.
6. Frost D, Meechoovet B, Wang T, Gately S, Giorgetti M, Shcherbakova I, et al. Î²-carboline compounds, including harmine, inhibit DYRK1A and tau phosphorylation at multiple Alzheimerâ€™s disease-related sites. PLoS One 2011;6:e19264.
7. Gibbs RD. Chemotaxonomy of Flowering Plants McGill-Queenâ€™s University Press: Montreal, Canada; 1974. p. 1-4.
8. Patel K, Gadewar M, Tripathi R, Prasad SK, Patel DK. A review on medicinal importance, pharmacological activity and bioanalytical aspects of beta-carboline alkaloid â€˜â€˜Harmineâ€™â€™. Asian Pac J Trop Biomed 2012;2:660-4.
9. Siddiqui S. A reinvestigation of the alkaloidal constituents of Peganum harmala. Pak J Sci Ind Res 1962;5:207-11.
10. Gunn JA. Pharmacological actions of harmine. Trans Roy Soc Edinburgh 1912;48:83.
11. Herraiz T, GonzÃ¡lez D, AncÃn-Azpilicueta C, ArÃ¡n VJ, GuillÃ©n H. Î²-Carboline alkaloids in Peganum harmala and inhibition of human monoamine oxidase (MAO). Food Chem Toxicol 2010;48:839-45.
12. Priyadharsini KS, Nirmala P Kumar PA. Effect of lutein in hypercholesterolemia-induced oxidative stress in male wistar rats. Int J Curr Pharm Res 2015;7:97-100.
13. Serge KB, Serges O-AA, Ludovic M, Elvis OT, Bernardin A, Francis F, et al. In vitro behaviour of Plasmodium falciparum strains by alkaloids and tannins extracted from the root of Mitragyna inermis, a medicinal plant. Int J Curr Pharm Res 2016;8:24-7.
14. Haghparast A, Farzin D, Ordikhani-Seyedlar M, Motaman S, Kermani M, Azizi P. Effects of apomorphine and Î²-carbolines on firing rate of neurons in the ventral pallidum in the rats. Behav Brain Res 2012;227:109-15.
15. Han YS, Kim JM, Cho JS, Lee CS, Kim DE. Comparison of the protective effect of indole Î²-carbolines and R-(-)-deprenyl against nitrogen species-induced cell death in an experimental culture model of Parkinson's disease. J Clin Neurol 2005;1:81-91.
16. Zhong Z, Tao Y, Yang H. Treatment with harmine ameliorates functional impairment and neuronal death following traumatic brain injury. Mol Med Rep 2015;12:1-7.
17. Ghori SS, Khan M, Tabassum R. Anti-inflammatory activity of Ficus dalhousiae miq roots ethanolic extract in wistar albino rats. Asian J Pharm Clin Res 2015;8:117-9.
18. Wang X, Wang H. Study on the antitumor effect of total harmala. J Chin Med Univ 1996;25:240-2.
19. RÃ©us GZ, Stringari RB, de Souza B, Petronilho F, Dal-Pizzol F, Hallak JE, et al. Harmine and imipramine promote antioxidant activities in prefrontal cortex and hippocampus. Oxid Med Cell Longev 2010;3:325-31.
20. Glennon RA, Dukat M, Grella B, Hong SS, Costantino L, Teitler M, et al. Binding of Î²-carbolines and related agents at serotonin (5-HT2 and 5-HT1A), dopamine (D2) and benzodiazepine receptors. Drug Alcohol Depend 2000;60:121-32.
21. Stanford SC. Central noradrenergic neurones and stress. Pharmacol Ther 1995;68:297-342.
22. Foote SL, Bloom FE, Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol Rev 1983;63:844-914.
23. Chaouloff F. Physiopharmacological interactions between stress hormones and central serotonergic systems. Brain Res Rev 1993;18:1-32.
24. Inoue T, Tsuchiya K, Koyama T. Regional changes in dopamine and serotonin activation with various intensity of physical and psychological stress in the rat brain. Pharmacol Biochem Behav 1994;49:911-20.
25. Chaouloff F, Berton O, MormÃ¨de P. Serotonin and stress. Neuropsychopharmacology 1999;21(2 Suppl):28Sâ€“32S.
26. Ong LK, Guan L, Damanhuri H, Goodchild AK, Bobrovskaya L, Dickson PW, et al. Neurobiological consequences of acute footschock stress: effects on tyrosine hydroxylase phosphorilation and activation in the rat brain and adrenal medulla. J Neurochem 2014;128:547-60.
27. Alba-Delgado C, Mico JA, SÃ¡nchez-BlÃ¡zquez P, Berrocoso E. Analgesic antidepressants promote the responsiveness of locus coeruleus neurons to noxious stimulation: implications for neuropathic pain. Pain 2012;153:1438-49.
28. Hirata H, Aston-Jones G. A novel long-latency response of locus coeruleus neurons to noxious stimuli: mediation by peripheral C-fibers. J Neurophysiol 1994;71:1752-61.
29. Kulkarni U, Patil BS, Hariprasanna RC, Borgaonkar PA, Hogade MG, Rabbani G. Formulation and development of fast dissolving meloxicam tablets by solid dispersion technique: for the effective treatment of dental pain. Int J Curr Pharm Res 2010;2:82-5.
30. Brierly DI, Davidson C. Developments in harmine pharmacology-Implications for ayahuasca use and drug dependence treatment. Prog Neuro-Psychopharmacol Biol Psychiatry 2012;39:263-72.
31. Jafar M, Mhg D, Shareef A. Enhancement of dissolution and anti-inflammatory effect of meloxicam using solid dispersions. Int J Appl Pharm 2010;2:22-7.
32. Endo Y, Yamauchi K, Fueta Y, Irie M. Changes of body temperature and plasma corticosterone level in rats during psychological stress induced by the communication box. Med Sci Monit 2001;7:1161-5.
33. Hall CS. Emotional behavior in the rat. Defecation and urination as measures of individual differences in the emotionality. J Comp Psychol 1934;18:385-403.
34. Lamprea MR, Cardenas FP, Setem J, Morato S. Thigmotactic responses in an open-field. Braz J Med Biol Res 2008;41:135-40.
35. Montgomery KC. The relation between fear induced by novel stimulation and exploratory behaviour. J Comp Physiol Psychol 1955;48:254-60.
36. Pellow S, Chopin P, File SE, Briley M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 1985;14:149-67.
37. Carobrez AP, Bertoglio LJ. Ethological and temporal analyses of anxiety-like behavior: the elevated plus-maze model 20 y on. Neurosci Biobehav Rev 2005;29:1193-205.
38. Belviranli M, Atalik KE, Okudan N, GÃ¶kbel H. Age and sex affect spatial and emotional behaviors in rats: the role of repeated elevated plus maze test. Neuroscience 2012;227:1-9.
39. Acevedo MB, Nizhnikov ME, Molina JC, Pautassi RM. The relationship between ethanol-induced activity and anxiolysis in the open field elevated plus maze, light-dark box, and ethanol intake in adolescent rats. Behav Brain Res 2014;265:203-15.
40. HascoÃ«t M, Bourin M, Dhonnchadha BA. The mouse light-dark paradigm: a review. Prog Neuropsychopharmacol Biol Psychiatry 2001;25:141-66.
41. Bourin M, HascoÃ«t M. The mouse light/dark box test. Eur J Pharmacol 2003;463:55-65.
42. Ramos A, Pereira E, Martins GC, Wehrmeister TD, IzÃdio GS. Integrating the open field, elevated plus-maze and light/dark box to assess different types of emotional behaviours in one single trial. Behav Brain Res 2008;193:277-88.
43. Matallah A, Hamri A, Bairi A, Tahar A, Tahraoui A. Anxiolytic effects of harmine injection on elevated plus-maze behavior in male wistar rats. G V 2015;15:605-12.
44. Gong W, Neill D, Justice JB. Conditioned place preference and locomotor activation produced by injection of psychostimulants into ventral pallidum. Brain Res 1996; 707:64-74.
45. Klitenick M, Deutch AY, Churchill L, Kalivas PW. Topography and functional role of dopaminergic projections from the ventral mesencephalic tegmentum to the ventral pallidum. Neuroscience 1992;50:371-86.
46. Iurlo M, Leone MG, SchilstrÃ¶m B, LinnÃ©r L, Nomikos G, Hertel P, et al. Effects of harmine on dopamine output and metabolism in rat striatum: role of monoamine oxidase-A inhibition. Psychopharmacology 2001;159:98-104.
47. Fortunato JJ, RÃ©us GZ, Kirsch TR, Stringari RB, Stertz L, Kapszinski F, et al. Acute harmine administration induces antidepressive-like effects and increases BDNF levels in the rat hippocampus. Prog NeuroPsychopharmacol and Biol Psychiatry 2009;33:1425-30.
48. Brierley DI, Davidson C. Harmine augments electrically evoked dopamine efflux in the nucleus accumbens shell. J Psychopharmacol 2013;27:98-108.
49. Avanzi V, BrandÃ£o ML. Activation of somatodendritic 5-HT 1A autoreceptors in the median raphe nucleus disrupts the contextual conditioning in rats. Behav Brain Res 2001;126:175-84.
50. Avanzi V, Castilho VM, Andrade TGCS, BrandÃ£o ML. Regulation of contextual conditioning by the median raphe nucleus. Brain Res 1998;790:178-84.
51. Wirtshafter D, Asin KE. Evidence that electrolytic median raphe lesions increase locomotion but not exploration. Physiol Behav 1982;28:749-54.
52. Napier TC, Potter PE. Dopamine in the rat ventral pallidum/ substantia innominata: biochemical and electrophysiological studies. Neuropharmacology 1989;28: 757-60.
53. Tiwari KD, Nagar H, Dwivedi G, Tripathi RK, Jena J. Evaluation of anti-anxiety activity of Plectranthus amboinicus (lour.) on rats. Asian J Pharm Clin Res 2012;5:110-3.
54. ThiÃ©bot MH, Jobert A, SoubriÃ© P. Chlordiazepoxide and GABA injected into raphÃ© dorsalis release the conditioned behavioural suppression induced in rats by a conflict procedure without nociceptive component. Neuro-pharmacology 1980;19:633-41.
55. Pawlak CR, Karrenbauer BD, Schneider P, Ho YJ. The elevated plus-maze test: Differential psychopharmacology of anxiety-related behavior. Emotion Rev 2010;4:1-19.
56. Turaskar AO, Bhongade SL, More SM, Dongarwar AS, Shende VS, Pande VB. Effects of Lippia nodiflora extracts on motor coordination, exploratory behavior pattern, locomotor activity, anxiety and convulsions on albino mice. Asian J Pharm Clin Res 2011;4(Suppl 1):87-92.
57. Umadevi P, Murugan S, Jennifer Suganthi S, Subakanmani S. Evaluation of antidepressant like activity of Cucurbita pepo seed extracts in rats. Int J Curr Pharm Res 2011;3:108-13.
58. Rosa VP, Vandresen N, Calixto AV, Kovaleski DF, Faria MS. Temporal analysis of the rat's behavior in the plus-maze: effect of midazolam. Pharmacol Biochem Behav 2000;67:177-82.
59. Degroot A, Treit D. Anxiety is functionally segregated within the septo-hippocampal system. Brain Res 2004;1001:60-71.
60. Shah AA, Sjovold T, Treit D. Inactivation of the medial prefrontal cortex with the GABAA receptor agonist muscimol increases open-arm activity in the elevated plus-maze and attenuates shock-probe burying in rats. Brain Res 2004;1028:112-5.
61. Johnson EO, Kamilaris TC, Chrousos GP, Gold PW. Mechanisms of stress: a dynamic overview of hormonal and bevavioral homeostasis. Neurosci Biobehav Rev 1992;16:115-30.
62. Pietrelli A, Lopez-Costa J, GoÃ±i R, Brusco A, Basso N. Aerobic exercise prevents age-dependent cognitive decline and reduces anxiety-related behaviors in middle-aged and old rats. Neuroscience 2012;202:252â€“66.
63. Khalilzadeh E, Hazrati R, Saiah GV, Hasannejad H. Opioidergic and cholinergic but not nitric oxide pathways are involved in antinociceptive activity of Vitex agnus-castus essential oil in the acute trigeminal model of pain in rat. Asian J Pharm Clin Res 2015;8:283-6.